Q-Sorb Co Q-10 Plus

Drug overview for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate):

Generic name: UBIDECARENONE (COENZYME Q10)/L-CARNITINE FUMARATE
Drug class: Coenzyme Q10
Therapeutic class: Alternative Therapy

No enhanced Introduction information available for this drug.

No enhanced Uses information available for this drug.

DRUG IMAGES

No Image Available

The following indications for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate) have been approved by the FDA:

Indications:
None.

Professional Synonyms:
None.

The following dosing information is available for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate):

Dosing
Administration
Dosing Information
Generic

No enhanced Dosing information available for this drug.

No enhanced Administration information available for this drug.

No dosing information available.

No generic dosing information available.

The following drug interaction information is available for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate):

Contraindicated
Severe
Moderate

There are 0 contraindications.

There are 0 severe interactions.

There are 0 moderate interactions.

The following contraindication information is available for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate):

Overview
Contraindicated
Severe
Moderate

Drug contraindication overview.

No enhanced Contraindications information available for this drug.

There are 1 contraindications. Absolute contraindication.

Contraindication List
Chronic kidney disease stage 5 (failure) GFr<15 ml/min

There are 0 severe contraindications.

There are 4 moderate contraindications. Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.

Moderate List
Biliary obstruction
Disease of liver
Hypotension
Seizure disorder

The following adverse reaction information is available for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate):

Overview
Severe
Less Severe

Adverse reaction overview.

No enhanced Common Adverse Effects information available for this drug.

There are 0 severe adverse reactions.

There are 5 less severe adverse reactions.

More Frequent	Less Frequent
None.	None.

Rare/Very Rare
Abnormal hepatic function tests Anorexia Diarrhea Gastrointestinal irritation Nausea

The following precautions are available for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate):

Pediatric
Pregnant
Lactation
Geriatric

No enhanced Pediatric Use information available for this drug.

Contraindicated

None

Severe Precaution

None

Management or Monitoring Precaution

None

No enhanced Pregnancy information available for this drug.

No enhanced Lactation information available for this drug.

No enhanced Geriatric Use information available for this drug.

The following prioritized warning is available for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate):

No warning message for this drug.

The following icd codes are available for Q-SORB CO Q-10 PLUS (ubidecarenone (coenzyme q10)/l-carnitine fumarate)'s list of indications:

No ICD codes found for this drug.